Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Change in Receivables (2016 - 2019)

Protara Therapeutics' Change in Receivables history spans 6 years, with the latest figure at -$7000.0 for Q4 2019.

  • Quarterly Change in Receivables rose 86.54% to -$7000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was -$17000.0 through Dec 2019, up 65.31% year-over-year, with the annual reading at -$17000.0 for FY2019, 65.31% up from the prior year.
  • Change in Receivables came in at -$7000.0 for Q4 2019, down from -$5000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $305000.0 in Q1 2015 to a low of -$182000.0 in Q4 2015.
  • The 5-year median for Change in Receivables is -$3500.0 (2017), against an average of $2111.1.
  • The largest YoY upside for Change in Receivables was 2133.33% in 2015 against a maximum downside of 768.75% in 2015.
  • Protara Therapeutics' Change in Receivables stood at -$182000.0 in 2015, then soared by 139.56% to $72000.0 in 2016, then plummeted by 137.5% to -$27000.0 in 2017, then tumbled by 92.59% to -$52000.0 in 2018, then soared by 86.54% to -$7000.0 in 2019.
  • Per Business Quant, the three most recent readings for TARA's Change in Receivables are -$7000.0 (Q4 2019), -$5000.0 (Q3 2019), and -$20000.0 (Q2 2019).